Global Transcranial Magnetic Stimulation (DTMS) device Market, By Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS), Others), Application (Alzheimer’s Disease, Depression, Parkinson’s Disease, Epilepsy, Others), End Use (Research, Diagnostics, Therapeutics) – Industry Trends and Forecast to 2029.
Deep Transcranial Magnetic Stimulation (DTMS) Device Market Analysis and Size
TMS is a helpful non-invasive brain stimulation method for studying the mechanisms of recovery, diagnosing the consequences of brain damage, and influencing post-lesional healing by non-invasive neuromodulation. TMS can be used as an intervention to boost or lower activity within a specific region or as a measurement tool to evaluate cortical excitability or inferred estimates of neurochemical concentration.
Data Bridge Market Research analyses that the deep transcranial magnetic stimulation (DTMS) device market which was USD 1.04 billion in 2021, and is estimated to reach USD 2.06 million by 2029, and is expected to grow at a CAGR of 8.9% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Deep Transcranial Magnetic Stimulation (DTMS) Device Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Deep Transcranial Magnetic Stimulator (dTMS), Repetitive Transcranial Magnetic Stimulator (rTMS), Others), Application (Alzheimer’s Disease, Depression, Parkinson’s Disease, Epilepsy, Others), End Use (Research, Diagnostics, Therapeutics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Brainsway Ltd. (U.S.), Dr. Langer Medical GmbH (Germany), MAG & More (Germany), Remed (U.S.), Axilum Robotics (France), Yiruide Co,,Ltd (China), Nexstim Plc (U.S.), Magstim (U.K.), Neuronetics (U.S.), Salience TMS Neuro Solutions (U.S.), Mag Venture Inc. (Denmark), and eNeura Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
The non-invasive treatment known as transcranial magnetic stimulation (TMS) stimulates brain nerve cells with magnetic fields to alleviate the symptoms of depression. When other forms of treatment for depression have failed, TMS is frequently utilised. Repetitive TMS, often known as rTMS, is the name of the depression treatment that uses repeated magnetic pulses. Deep transcranial magnetic stimulation, also known as deep TMS or dTMS, is a type of TMS developed by BrainsWay. It employs a different magnetic coil than rTMS, known as the H-1 coil. BrainsWay invented this coil in 2000, and the FDA approved it as a treatment for major depression in 2013.
Global Deep Transcranial Magnetic Stimulation (DTMS) Device Market Dynamics
Drivers
- Expanding uses of transcranial magnetic stimulation
The deep transcranial magnetic stimulation (DTMS) device market is anticipated to have considerable growth from 2022 to 2029 as a result of the expanding uses of transcranial magnetic stimulation in the diagnosis and treatment of neurological illnesses. Numerous factors, including an ageing population with an increase in age-related brain illnesses, advantageous reimbursement policies, and the introduction of innovative, high-tech goods by manufacturers, are expected to contribute to the market's expansion.
- Rise in depressive disorder and obsessive disorder
According to the World Health Organization, dispersion affects more than 264 million individuals and is distinct from typical mood swings and fleeting emotional reactions to difficulties in daily life. The prevalence of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD) is also rising, which is a crucial element in the market's expansion.
Opportunities
- Rising awareness regarding deep transcranial magnetic stimulation
The deep transcranial magnetic stimulation (DTMS) device market's growth is fuelled during the forecast period as a result of rising awareness regarding deep transcranial magnetic stimulation (DTMS) device amongst professionals. This will provide beneficial opportunities for the deep transcranial magnetic stimulation (DTMS) device market growth.
Restraints/Challenges
- Presence of alternate therapies
More patients are using the electroconvulsive therapy which has a high rate of success in treating psychotic depression which will obstruct the market's growth rate.
Recent Developments
- In March 2019, Brain Way Ltd., an Israeli business, stated that it has acquired a sizable multi-channel transcranial magnetic stimulation patent portfolio from TMS innovation. Additionally, it also entered into a contract with Standford University for an exclusive option to obtain patents related to multichannel TMS
- In May 2019, TMS-Cobot, which is a tool for the precise application of transcranial magnetic stimulation, received FDA 510(k) clearance from the France-based business Axilum Robotics. The TMS robot is the first robot to help medical personnel give DTMS
This deep transcranial magnetic stimulation (DTMS) device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the deep transcranial magnetic stimulation (DTMS) device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Deep Transcranial Magnetic Stimulation (DTMS) Device Market Scope
The deep transcranial magnetic stimulation (DTMS) device market is segmented on the basis of type, application and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Deep Transcranial Magnetic Stimulator (dTMS)
- Repetitive Transcranial Magnetic Stimulator (rTMS)
- Others
Application
- Alzheimer’s Disease
- Depression
- Parkinson’s Disease
- Epilepsy
- Others
End Use
- Research
- Diagnostics
- Therapeutics
Deep Transcranial Magnetic Stimulation (DTMS) Device Market Regional Analysis/Insights
The deep transcranial magnetic stimulation (DTMS) device market is analysed and market size insights and trends are provided by country, type, application and end use as referenced above.
The countries covered in the deep transcranial magnetic stimulation (DTMS) device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the deep transcranial magnetic stimulation (DTMS) device market due to the rising awareness and presence of highly skilled physicians in the region, favourable reimbursement policies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the increasing prevalence of physiological and neurological disorders and rising government initiatives in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The deep transcranial magnetic stimulation (DTMS) device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for deep transcranial magnetic stimulation (DTMS) device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the deep transcranial magnetic stimulation (DTMS) device market. The data is available for historic period 2010-2020.
Competitive Landscape and Deep Transcranial Magnetic Stimulation (DTMS) Device Market Share Analysis
The deep transcranial magnetic stimulation (DTMS) device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to deep transcranial magnetic stimulation (DTMS) device market.
Some of the major players operating in the deep transcranial magnetic stimulation (DTMS) device market are:
- Brainsway Ltd. (U.S.)
- Dr. Langer Medical GmbH (Germany)
- MAG & More (Germany)
- Remed (U.S.)
- Axilum Robotics (France)
- Yiruide Co,,Ltd (China)
- Nexstim Plc (U.S.)
- Magstim (U.K.)
- Neuronetics (U.S.)
- Salience TMS Neuro Solutions (U.S.)
- Mag Venture Inc. (Denmark)
- eNeura Inc. (U.S.)
SKU-